CSL - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeCSL
CSL logo

CSL

0 followers

CSLLY

Performance

About CSL

CSL is a global biotechnology company composed of CSL Behring, CSL Seqirus, and CSL Vifor, delivering lifesaving medicines and vaccines across more than 100 countries. The company focuses on rare and serious diseases, plasma-derived and recombinant therapies, influenza vaccines, and therapies for iron deficiency and nephrology, with R&D and manufacturing capabilities spanning multiple continents. Since 1916, CSL has combined commercial strength with research-driven innovation to improve patient outcomes worldwide. Its three business units concentrate on plasma/biologics therapy, vaccines, and iron/Kidney health, affirming CSL’s commitment to public health and life-saving care.

Recent News

Recent Deals

Key Team Members

Bill Mezzanotte

Executive Vice President, Head of Research & Development and Chief Medical Officer

Andy Schmeltz

Chief Commercial Officer

Kate Priestman

Chief Corporate & External Affairs Officer

Dave Ross

Senior Vice President and General Manager, CSL Seqirus

Mary Oates

Executive Vice President and Chief Operating Officer

Key Facts

HQ Location

Melbourne, Australia

Founded

1916

Employees

over-10K

Status

Public

Website

https://csl.com